Petredis Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SP
CRM
SW
AWA
SFA
HPC
Petredis Investment Advisors's AMGN Position: Q2 2026 in Review
Petredis Investment Advisors reduced its Amgen (AMGN) stake by 13% in Q2 2026, selling an estimated $51.3K and leaving 1,040 shares worth $377K. The position accounts for 0.03% of the portfolio, ranked #105.
Petredis Investment Advisors first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $501K in Q3 2024. 659 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Petredis Investment Advisors held 1,040 shares of Amgen worth $377K as of Q2 2026.
- Petredis Investment Advisors sold 150 Amgen shares in Q2 2026, an estimated $51.3K.
- Amgen made up 0.03% of Petredis Investment Advisors's portfolio in Q2 2026, its #105 holding.
- Petredis Investment Advisors first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
- Petredis Investment Advisors's Amgen position peaked at $501K in Q3 2024.
- 659 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Petredis Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.